Werbung
Werbung

GSK

GSK logo

GSK plc - ADR

50.22
USD
Gesponsert
-0.40
-0.79%
08. Jan., 15:59 UTC -5
Geschlossen
exchange

Vor-Markt

50.53

+0.31
+0.63%

GSK Ergebnisberichte

Positives Überraschungsverhältnis

GSK übertreffen die 32 der letzten 39Schätzungen.

82%

Nächster Bericht

Datum des nächsten Berichts
04. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$8.70B
/
$0.23
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+1.78%
/
-58.18%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+7.17%
/
--

GSK plc - ADR earnings per share and revenue

On 29. Okt. 2025, GSK reported earnings of 0.55 USD per share (EPS) for Q3 25, beating the estimate of 0.48 USD, resulting in a 12.80% surprise. Revenue reached 8.55 milliarde, compared to an expected 8.57 milliarde, with a -0.28% difference. The market reacted with a +5.10% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of 0.23 USD, with revenue projected to reach 8.70 milliarde USD, implying an decrease of -58.18% EPS, and increase of 1.78% in Revenue from the last quarter.
FAQ
For Q3 2025, GSK plc - ADR reported EPS of $0.55, beating estimates by 12.8%, and revenue of $8.55B, -0.28% below expectations.
The stock price moved up 5.1%, changed from $43.70 before the earnings release to $45.93 the day after.
The next earning report is scheduled for 04. Feb. 2026.
Based on 9 analysts, GSK plc - ADR is expected to report EPS of $0.23 and revenue of $8.70B for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung